Larimar Therapeutics Reports Second Quarter 2024 Operating and Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/24/2026

1. META
2. ORCL
3. OKTA
4. SPY
5. P
6. MCD
7. MGM
8. ACAD
9. KGC
10. SFIX

Go back to Larimar Therapeutics Reports Second Quarter 2024 Operating and Financial Results
(NASDAQ: LRMR) Delayed: 3.47 -0.4 (10.34%)
Previous Close $3.87    52 Week High $ 
Open $3.85    52 Week Low $ 
Day High $3.86    P/E N/A 
Day Low $3.40    EPS $ 
Volume 2,290,741